L-tert-Leucine, cataloged under CAS number 20859-02-3, is a fascinating amino acid derivative with a distinct chemical structure that lends itself to a variety of critical applications. As a manufacturer and supplier, NINGBO INNO PHARMCHEM CO.,LTD. is proud to offer this compound, known for its role in synthetic drugs and as a vital component in nutritional fortifiers and animal feed additives. Its molecular formula is C6H13NO2, and it is often supplied in a white crystalline powder form. The compound's predicted boiling point is approximately 217.7±23.0 °C, indicating its stability under various processing conditions.

The primary utility of L-tert-Leucine lies in its function as a chiral reagent in asymmetric synthesis. This is particularly important in the pharmaceutical industry, where the stereochemistry of drug molecules can profoundly influence their biological activity and safety profile. By using L-tert-Leucine as a building block, chemists can precisely control the chirality of the synthesized compounds, leading to more effective and targeted therapies. This makes it an invaluable intermediate for the synthesis of specialized amino acid derivatives and peptides that are integral to many modern medicines. The search for superior amino acid derivatives for drug development often leads researchers to compounds like L-tert-Leucine, which offer unique structural advantages.

Furthermore, L-tert-Leucine's application as a nutrient fortifier highlights its broader impact. In the food and supplement industries, it contributes to improving the nutritional value of products. Similarly, in the animal feed sector, it is used to enhance the quality and efficacy of feed formulations, supporting animal health and productivity. NINGBO INNO PHARMCHEM CO.,LTD. ensures a reliable supply of this critical chemical, enabling businesses to meet their production demands. When considering the purchase of L-tert-Leucine, understanding its role in these varied sectors underscores its importance as a versatile chemical intermediate.